Biobank for the Identification of Biomarkers in Lung Cancer (BIRD, Biomarkers in Respiratory Disease)
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity Hospital, Toulouse
About this trial
The BIRD biobank aims at collecting clinical and biological data from patients suffering from a chronic respiratory disease. The lung cancer subpopulation will be divided into two cohorts to identify biomarkers of cancer. One cohort will include patients with supra-centimetric lung nodule(s) whether surveillance, bronchoscopic or radio-guided biopsy or surgery is indicated, patients suspected of lung cancers requiring diagnostic and/or therapeutic bronchial endoscopy and patients with a known early stage lung cancer (early-stage cohort). The second cohort will include known advanced stage lung cancers (III-IV).
Eligibility criteria
Qualifiers
Patients with 1 to 3 lung nodules including one > 1 cm seen on chest CT
OR: patients with suspected lung cancer requiring diagnostic and/or therapeutic bronchial endoscopy
OR: Patient with histologically confirmed lung cancer, whether early stages prior to surgery, locally advanced or metastatic, included before the start of any anti-cancer treatment.
Patient affiliated or beneficiary of a social security scheme
Disqualifiers
Patient deprived of liberty on administrative or judicial decision, or patient under guardianship, curators or safeguard of justice
Female patients who are pregnant or breastfeeding
Trial design
Treatments tested in this trial
- Extra blood sampling, Non-invasive or leftover samples or medical waste
Treatment groups
3,000 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov